Melittin, a honeybee venom‑derived antimicrobial peptide, may target methicillin‑resistant Staphylococcus aureus

Related Experiment Video

Updated: Apr 4, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

25.3K

Ji Hae Choi1, A Yeung Jang1, Shunmei Lin1

  • 1Radiation Biotechnology Research Division, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup Si, North Jeolla 580‑185, Republic of Korea.

Molecular Medicine Reports
|September 3, 2015
PubMed

Insights

Melittin, a component of bee venom, shows potent antibacterial activity against Methicillin-resistant Staphylococcus aureus (MRSA). This study found melittin effective in treating MRSA infections and promoting wound healing in mice.

Area of Science:

  • Microbiology
  • Pharmacology
  • Biochemistry

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant challenge due to antibiotic resistance.
  • Honeybee venom is a traditional remedy with known anti-inflammatory and antimicrobial properties.
  • Limited research exists on the therapeutic potential of bee venom components against MRSA.

Purpose of the Study:

  • To evaluate the antibacterial activity of honeybee venom and melittin against MRSA.
  • To assess the in vivo efficacy of melittin in treating MRSA infections and promoting wound healing.

Main Methods:

  • In vitro testing of bee venom and melittin against MRSA and other Gram-positive bacteria.
  • In vivo studies using MRSA-infected mouse models to evaluate treatment outcomes for bacteraemia and skin wounds.

Main Results:

  • Both bee venom and melittin demonstrated significant antibacterial activity, particularly against MRSA strains.
  • Melittin treatment successfully rescued MRSA-infected mice from bacteraemia and accelerated the healing of skin wounds.
  • Bee venom showed comparable activity, but melittin was the primary driver of therapeutic effects.

Conclusions:

  • Melittin exhibits promising antimicrobial properties against MRSA.
  • Melittin is a potential therapeutic agent for enhancing the healing of MRSA-induced wounds.
  • Further investigation into melittin as an MRSA treatment is warranted.

More Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.5K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.2K

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
41
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
111
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.4K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
79
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
62
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
72